Mylan Institutional
Manufacturing · United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
United StatesWebsite
www.fulphila.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
1
1
1
1
1
1
About Mylan Institutional
Biocon Biologics specializes in biosimilars, particularly promoting FULPHILA®, the first FDA-approved pegfilgrastim biosimilar designed to reduce the risk of febrile neutropenia in patients undergoing chemotherapy. The company is dedicated to being a long-term partner in the oncology sector, providing extensive support and resources for healthcare providers and patients alike. Their offerings include co-pay assistance, insurance navigation, and a comprehensive patient support program to ensure access to their products. Biocon Biologics serves healthcare providers and patients dealing with nonmyeloid malignancies that require treatment for chemotherapy-induced complications.Explore more
Mylan Institutional Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Mylan Institutional your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Product Launch: Get notified when Mylan Institutional launches new products
Congratulate Masked Content for being promoted to Masked Content at Mylan Institutional
Funding: Get notified immidiatlly once Mylan Institutional has new funding data
Mylan Institutional, which may be a good buyer, showed buying intent in Masked Content Topic
Check if Mylan Institutional has recently received funding, and reach out quickly before it becomes old news!
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Earning: See what the market has to say on Mylan Institutional recently announced quarterly report
Click to see if Mylan Institutional had a recent Job posting/layoffs
Check out if Mylan Institutional is spiking on competitors!
Website visits: Recent activity has been detected on your website
Recommended Actions
Find VP level buyers at Mylan Institutional
Find more new buyers
Compare Similar Companies to Mylan Institutional
Compare insights from companies similar to Mylan Institutional, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Mylan Institutional is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Mylan Institutional is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Mylan Institutional.
Mylan Institutional Tech Stack
A closer look at the technologies used by Mylan Institutional
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Mylan Institutional
Sign Up For FreeTo access detailed company insights
Biocon Biologics specializes in biosimilars, particularly promoting FULPHILA®, the first FDA-approved pegfilgrastim biosimilar designed to reduce the risk of febrile neutropenia in patients undergoing chemotherapy. The company is dedicated to being a long-term partner in the oncology sector, providing extensive support and resources for healthcare... Read More
